Methodological aspects of measuring oxidized low density lipoproteins in human serum and plasma

By Perman J.   Fagerlund C.   Hulthe J.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 64, Iss. 8, 2004-11 ,pp. : 753-756

Informa Healthcare

Access to resources Recommend Favorite

Modified Low-Density Lipoproteins and High-Density Lipoproteins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 3-4, 2006-08 ,pp. : 322-345

Karger

Access to resources Recommend Favorite

Relation of myeloperoxidase promoter polymorphism and long‐term hormone replacement therapy to oxidized low‐density lipoprotein autoantibodies in postmenopausal women

By Mäkelä R.   Dastidar P.   Jokela H.   Jaakkola O.   Saarela M.   Punnonen R.   Lehtimäki T.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 66, Iss. 5, 2006-08 ,pp. : 371-384

Informa Healthcare

Access to resources Recommend Favorite

AUTOANTIBODIES AGAINST OXIDIZED LOW‐DENSITY LIPOPROTEINS IN OLDER STROKE PATIENTS

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 45, Iss. 1, 1997-01 ,pp. : 125-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low‐density lipoprotein receptor activity in Epstein‐Barr virus‐transformed lymphocytes from heterozygotes for the D374Y mutation in the PCSK9 gene

By Holla Ø. L.   Cameron J.   Berge K. E.   Kulseth M. A.   Ranheim T.   Leren T. P.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 66, Iss. 4, 2006-06 ,pp. : 317-328

Informa Healthcare

Access to resources Recommend Favorite